ACADIA PHARMACEUTICALS INC 10-Q filing
Filed 2026-05-07 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-209731
- Form type
- 10-Q
- CIK
- 0001070494
- Primary document
- https://www.sec.gov/Archives/edgar/data/1070494/000119312526209731/acad-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ACADIA PHARMACEUTICALS INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $268.1M | - | - |
| Cost Of Revenue | $24.8M | - | - |
| Operating Income | $-4.6M | - | - |
| Net Income | $3.6M | - | - |
| Eps Basic | 0.02 | - | - |
| Eps Diluted | 0.02 | - | - |
| Cash And Equivalents | $282.2M | - | - |
| Total Assets | $1.6B | - | - |
| Total Liabilities | $357.2M | - | - |
| Shareholders Equity | $1.2B | - | - |
| Operating Cash Flow | $34.0M | - | - |
| Capital Expenditures | $5.2M | - | - |